Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Dow
Express Scripts
McKinsey
Medtronic

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

ATENOLOL AND CHLORTHALIDONE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Atenolol And Chlorthalidone, and what generic alternatives are available?

Atenolol And Chlorthalidone is a drug marketed by Alvogen, Mylan, Nostrum Labs, Pliva, Sun Pharm Industries, Watson Labs, and Zydus Pharms. and is included in seven NDAs.

The generic ingredient in ATENOLOL AND CHLORTHALIDONE is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.

Drug patent expirations by year for ATENOLOL AND CHLORTHALIDONE
Recent Clinical Trials for ATENOLOL AND CHLORTHALIDONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Agenzia Italiana del FarmacoPhase 4
Federico II UniversityPhase 4
VA Office of Research and DevelopmentN/A

See all ATENOLOL AND CHLORTHALIDONE clinical trials

Pharmacology for ATENOLOL AND CHLORTHALIDONE
Synonyms for ATENOLOL AND CHLORTHALIDONE
2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide; 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
73677-19-7
AC1L59UI
Atenolol mixture with chlorthalidone
Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, mixt. with 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide
Blokium-Diu
C14H11ClN2O4S.C14H22N2O3
CTK2H8192
Igroseles
LS-177063
Normopresil
SCHEMBL1649159
TENORETIC 100
TENORETIC 50

US Patents and Regulatory Information for ATENOLOL AND CHLORTHALIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 072302-002 May 31, 1990 AB RX No No   Start Trial   Start Trial   Start Trial
Pliva ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074107-001 Sep 24, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074203-002 Oct 31, 1993 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 073665-002 Jul 2, 1992 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Dow
Express Scripts
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.